BioSpace News Archive

Morphic Therapeutic announced that its management team will participate in the upcoming Jefferies London Healthcare Conference and Evercore ISI HealthCONx Conference.

Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal (GI) diseases, today reported its financial results for the third quarter 2023 and provided a business outlook.

Roivant announced the appointment of Mayukh Sukhatme, M.D., to its Board of Directors, effective immediately.

Ardelyx, Inc. announced that Ardelyx management will participate in a fireside chat at the Jefferies London Healthcare Conference on Thursday, November 16, 2023, at 8:30 a.m. GMT in London, UK.

Boston Pharmaceuticals today announced new data supporting BOS-580, its investigational, long-acting fibroblast growth factor 21 (FGF21) analog for the treatment of non-alcoholic steatohepatitis (NASH). Results support a once-monthly dosing schedule for BOS-580 and the positive effects of treatment for people living with NASH who are at risk for or have type 2 diabetes.

InterAx Biotech AG announces being awarded a highly competitive and prestigious grant to apply its drug discovery and development platform to the breakthrough technology programs sponsored by the EU commission.

Fortress Biotech, Inc. today announced the pricing of its public offering of an aggregate of 5,885,000 units, at a public offering price of $1.70 per unit, consisting of (i) one share of common stock.

Biomerica, Inc. today announced that it will participate in the 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023, at the Sheraton New York Times Square Hotel in New York City.

Milestone Scientific Inc. (NYSE:MLSS) today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, November 15, 2023, to discuss the company’s financial results for the third quarter ended September 30, 2023, as well as the company’s corporate progress and other developments.

Thryv Therapeutics is pleased to announce its selection as a featured presenter at the Piper Sandler 35th Annual Healthcare Conference, held from November 28th to November 30th, 2023, at Lotte New York Palace in New York City.